UCL Discovery
UCL home » Library Services » Electronic resources » UCL Discovery

Brief report: effects of methylphenidate on the light adapted electroretinogram

Constable, Paul A; Skuse, David H; Thompson, Dorothy A; Lee, Irene O; (2025) Brief report: effects of methylphenidate on the light adapted electroretinogram. Documenta Ophthalmologica , 150 pp. 25-32. 10.1007/s10633-024-10000-3.

[thumbnail of Skuse_Brief Report Meth Preprint.pdf] Text
Skuse_Brief Report Meth Preprint.pdf
Access restricted to UCL open access staff until 16 December 2025.

Download (508kB)

Abstract

Purpose: To explore changes in the electroretinogram (ERG) following methylphenidate use in attention-deficit/hyperactivity disorder (ADHD). // Methods: Light adapted ERGs were recorded in five individuals (3 male and 2 female, age range 13.6–21.8 years) with a diagnosis of ADHD. Six flash strengths ranging from 71 to 446 Td.s were qualitatively evaluated following a minimum of 24 h without any medication and from 2 to 6 h following the individuals’ standard slow-release (XL) methylphenidate dose that ranged from 18 to 60 mg. // Results: Of the six flash strengths, the 178 Td.s strength revealed changes in four of the five participants with a median 27.4% increase in b-wave amplitude. For three individuals there was an increase in the a-wave amplitude and for two of the same individuals there was also a noticeable pronouncement of the oscillatory potentials. The a-wave amplitude showed a greatest median increase at the 446 Td.s flash strength of 25.8%. One individual – on the highest dose (60 mg) exhibited no morphologically distinct changes in the ERG. No differences in the time to peaks of the a- and b-wave were observed for any individual. // Conclusion: The a- and b-wave amplitudes of the light adapted ERG could provide insights into the effect of methylphenidate in ADHD.

Type: Article
Title: Brief report: effects of methylphenidate on the light adapted electroretinogram
Location: Netherlands
DOI: 10.1007/s10633-024-10000-3
Publisher version: https://doi.org/10.1007/s10633-024-10000-3
Language: English
Additional information: This version is the author accepted manuscript. For information on re-use, please refer to the publisher’s terms and conditions.
Keywords: Dopamine; Attention deficit hyperactivity disorder; Retina; Medication
UCL classification: UCL
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > UCL GOS Institute of Child Health
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > UCL GOS Institute of Child Health > Developmental Biology and Cancer Dept
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > UCL GOS Institute of Child Health > Population, Policy and Practice Dept
URI: https://discovery.ucl.ac.uk/id/eprint/10205825
Downloads since deposit
Loading...
2Downloads
Download activity - last month
Loading...
Download activity - last 12 months
Loading...
Downloads by country - last 12 months
Loading...

Archive Staff Only

View Item View Item